{"id":"https://openalex.org/W2083171728","doi":"https://doi.org/10.1016/s0924-977x(10)70766-5","title":"P.3.f.001 The impact of language and culture on the delivery of standardised rater training for the PANSS across seven countries","display_name":"P.3.f.001 The impact of language and culture on the delivery of standardised rater training for the PANSS across seven countries","alternate_titles":[],"publication_year":2010,"publication_date":"2010-08-01","ids":{"openalex":"https://openalex.org/W2083171728","doi":"https://doi.org/10.1016/s0924-977x(10)70766-5","mag":"2083171728"},"language":"en","primary_location":{"id":"doi:10.1016/s0924-977x(10)70766-5","doi":"https://doi.org/10.1016/s0924-977x(10)70766-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-977x(10)70766-5","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2083171728"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010669691","display_name":"Ashleigh DeFries","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. DeFries","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077107871","display_name":"Christian Yavorsky","orcid":"https://orcid.org/0000-0002-0411-3577","observed_orcids":["https://orcid.org/0000-0002-0411-3577"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Yavorsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035258684","display_name":"Stacy Liechti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Liechti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108488606","display_name":"M. Opler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Opler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"20","issue":null,"first_page":"S513","last_page":"S513"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.39969998598098755,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.39969998598098755,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10467","display_name":"Psychometric Methodologies and Testing","score":0.0697999969124794,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13309","display_name":"Reliability and Agreement in Measurement","score":0.062300000339746475,"subfield":{"id":"https://openalex.org/subfields/1804","display_name":"Statistics, Probability and Uncertainty"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.8690000176429749},{"id":"https://openalex.org/keywords/rater-training","display_name":"rater training","score":0.7549999952316284},{"id":"https://openalex.org/keywords/language-and-culture","display_name":"language and culture","score":0.6340000033378601},{"id":"https://openalex.org/keywords/cross-cultural-adaptation","display_name":"cross-cultural adaptation","score":0.5199999809265137},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.32199999690055847},{"id":"https://openalex.org/keywords/scale-reliability","display_name":"scale reliability","score":0.328000009059906},{"id":"https://openalex.org/keywords/inter-rater-reliability","display_name":"inter-rater reliability","score":0.6840000152587891},{"id":"https://openalex.org/keywords/indacaterol","display_name":"indacaterol","score":0.5720000267028809},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9380000233650208},{"id":"https://openalex.org/keywords/long-acting-bronchodilators","display_name":"long-acting bronchodilators","score":0.921999990940094},{"id":"https://openalex.org/keywords/dry-powder-inhaler","display_name":"dry powder inhaler","score":0.8679999709129333},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.8209999799728394},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6240000128746033},{"id":"https://openalex.org/keywords/serum-potassium","display_name":"serum potassium","score":0.5709999799728394},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.6850000023841858},{"id":"https://openalex.org/keywords/qtc-interval","display_name":"QTc interval","score":0.8169999718666077},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.453000009059906},{"id":"https://openalex.org/keywords/pulse-rate","display_name":"pulse rate","score":0.6420000195503235},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2778884479","wikidata":"https://www.wikidata.org/wiki/Q425654","display_name":"Indacaterol","level":4,"score":0.9892809391021729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8823229074478149},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8312711119651794},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7693930864334106},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.7214031219482422},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5724788904190063},{"id":"https://openalex.org/C2780333948","wikidata":"https://www.wikidata.org/wiki/Q653305","display_name":"Spirometry","level":3,"score":0.5305951833724976},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.5166566967964172},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5115566849708557},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.481403112411499},{"id":"https://openalex.org/C2776719499","wikidata":"https://www.wikidata.org/wiki/Q424333","display_name":"Salmeterol","level":3,"score":0.4448756277561188},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.411773681640625},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.39493614435195923},{"id":"https://openalex.org/C2781018748","wikidata":"https://www.wikidata.org/wiki/Q927234","display_name":"Bronchodilator","level":3,"score":0.3804689347743988},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.364688515663147},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0924-977x(10)70766-5","doi":"https://doi.org/10.1016/s0924-977x(10)70766-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-977x(10)70766-5","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046142442","https://openalex.org/W1522553747","https://openalex.org/W2144414587","https://openalex.org/W2089834473","https://openalex.org/W2020662437","https://openalex.org/W1952594708","https://openalex.org/W2004780292","https://openalex.org/W2165224300","https://openalex.org/W2011453547"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2083171728","counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
